January 11, 2018 / 1:25 PM / Updated 13 minutes ago BRIEF-Elanco, Aratana Announce Marketing Authorization Of Galliprant In Europe Reuters Staff 1 Min Read 
Jan 11 (Reuters) - Aratana Therapeutics Inc: 
* ELANCO, ARATANA ANNOUNCE MARKETING AUTHORIZATION OF GALLIPRANTÂ® (GRAPIPRANT TABLETS) IN EUROPE Source text for Eikon: Further company coverage: